SG10201807891UA - Hexose derivatives, preparation and uses thereof - Google Patents

Hexose derivatives, preparation and uses thereof

Info

Publication number
SG10201807891UA
SG10201807891UA SG10201807891UA SG10201807891UA SG10201807891UA SG 10201807891U A SG10201807891U A SG 10201807891UA SG 10201807891U A SG10201807891U A SG 10201807891UA SG 10201807891U A SG10201807891U A SG 10201807891UA SG 10201807891U A SG10201807891U A SG 10201807891UA
Authority
SG
Singapore
Prior art keywords
preparation
hexose derivatives
hexose
derivatives
ch2c
Prior art date
Application number
SG10201807891UA
Other languages
English (en)
Inventor
Maycock Christopher David
Bordalo Ventura Centeno Lima Maria Rita Mendes
Lourenço Eva Correia
Dos Santos Maria Helena Dias
Cunha Miguel Ana Sofia Da
Original Assignee
Faculdade De Ciencias Da Univ De Lisboa
Instituto De Tecnologia Quim E Biologica Antonio Xavier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faculdade De Ciencias Da Univ De Lisboa, Instituto De Tecnologia Quim E Biologica Antonio Xavier filed Critical Faculdade De Ciencias Da Univ De Lisboa
Publication of SG10201807891UA publication Critical patent/SG10201807891UA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/06Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing nitrogen as ring hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/465Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Saccharide Compounds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG10201807891UA 2014-03-14 2015-03-13 Hexose derivatives, preparation and uses thereof SG10201807891UA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201461953392P 2014-03-14 2014-03-14

Publications (1)

Publication Number Publication Date
SG10201807891UA true SG10201807891UA (en) 2018-10-30

Family

ID=53264710

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201807891UA SG10201807891UA (en) 2014-03-14 2015-03-13 Hexose derivatives, preparation and uses thereof
SG11201607530XA SG11201607530XA (en) 2014-03-14 2015-03-13 Hexose derivatives, preparation and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201607530XA SG11201607530XA (en) 2014-03-14 2015-03-13 Hexose derivatives, preparation and uses thereof

Country Status (12)

Country Link
US (2) US11708387B2 (https=)
EP (1) EP3116886A1 (https=)
JP (2) JP7067867B2 (https=)
KR (3) KR102651029B1 (https=)
CN (2) CN106573952A (https=)
BR (1) BR112016021231B1 (https=)
CA (1) CA2942635C (https=)
IL (1) IL247531B (https=)
MX (1) MX386787B (https=)
RU (1) RU2731563C2 (https=)
SG (2) SG10201807891UA (https=)
WO (1) WO2015137838A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102651029B1 (ko) * 2014-03-14 2024-03-25 파쿠우다지 지 씨엔씨아스 다 우니베르시다지 지 리스보아 헥소스 유도체, 그의 제제 및 용도
FR3061013B1 (fr) * 2016-12-22 2020-04-17 Greenpharma Composition contenant le digeneaside, son procede d'obtention et son utilisation cosmetique, veterinaire ou nutraceutique
US12098162B2 (en) * 2017-11-13 2024-09-24 Extremochem, Lda Neutral glycosylated amides and dianionic glucuronidated acids as stabilizers for biological molecules
CN116251110B (zh) * 2022-11-18 2025-02-14 广东药科大学 β-D-吡喃葡萄糖基-乳酸及其衍生物在制备治疗代谢性疾病、炎症药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060099567A1 (en) * 2004-04-08 2006-05-11 Biomatrica, Inc. Integration of sample storage and sample management for life science
DE102004031588A1 (de) * 2004-06-30 2006-02-09 Symrise Gmbh & Co. Kg Verwendung von Äpfelsäureglucosiden als Geschmacksstoffe
PT103442A (pt) * 2006-02-24 2007-08-31 Stab Vida Investigacao E Servi Derivados sintéticos de manosil-glicerato para a estabilização e/ou preservação de biomateriais
PT103441A (pt) 2006-02-24 2007-08-24 Stab Vida Investigacao E Servi Utilização de solutos compatíveis para melhorar o desempenho de técnicas utilizando materiais biológicos imobilizados
DE102010038496A1 (de) 2010-07-27 2012-02-02 Henkel Ag & Co. Kgaa Stabilisierte flüssige enzymhaltige Tensidzubereitung
DE102011118027A1 (de) * 2011-09-12 2013-03-14 Henkel Ag & Co. Kgaa Verfahren zur Anpassung eines Hydrolytischen Enzyms an eine das hydrolytische Enzym stabilisierende Komponente
KR102651029B1 (ko) 2014-03-14 2024-03-25 파쿠우다지 지 씨엔씨아스 다 우니베르시다지 지 리스보아 헥소스 유도체, 그의 제제 및 용도
JP2020097767A (ja) 2018-12-18 2020-06-25 株式会社東芝 表面処理剤、これを用いた積層体、及び無電解めっき製品

Also Published As

Publication number Publication date
SG11201607530XA (en) 2016-10-28
BR112016021231B1 (pt) 2021-07-27
KR102401853B1 (ko) 2022-05-25
US12590117B2 (en) 2026-03-31
JP7077361B2 (ja) 2022-05-30
US20230357301A1 (en) 2023-11-09
IL247531A0 (en) 2016-11-30
CA2942635A1 (en) 2015-09-17
KR20220153571A (ko) 2022-11-18
KR20240045328A (ko) 2024-04-05
JP2017516838A (ja) 2017-06-22
EP3116886A1 (en) 2017-01-18
MX386787B (es) 2025-03-19
US20180170955A1 (en) 2018-06-21
IL247531B (en) 2021-04-29
JP2020183383A (ja) 2020-11-12
CA2942635C (en) 2022-12-06
RU2016140337A3 (https=) 2018-10-30
CN106573952A (zh) 2017-04-19
KR20160145584A (ko) 2016-12-20
BR112016021231A2 (en) 2018-07-10
KR102651029B1 (ko) 2024-03-25
CN115448964A (zh) 2022-12-09
US11708387B2 (en) 2023-07-25
KR102828884B1 (ko) 2025-07-02
JP7067867B2 (ja) 2022-05-16
MX2016011808A (es) 2017-05-09
RU2016140337A (ru) 2018-04-17
RU2731563C2 (ru) 2020-09-04
WO2015137838A1 (en) 2015-09-17

Similar Documents

Publication Publication Date Title
WO2016077464A8 (en) Amino acid derivatives and their uses
BR112014017749A8 (pt) Composto alquinilbenzeno 3,5-dissubstituído e sal do mesmo
MX2015010106A (es) Moduladores de la proteina activadora de 5-lipoxigenasa.
PH12015502546A1 (en) 3-(4-isobutyl-2-methylphenyl) propanal as perfume ingredient
BR112016029333A2 (pt) síntese de compostos de carbamoilpiridona policíclico
PH12015501993B1 (en) Pyrazole-amide compound and medicinal uses therefor
PH12019501178A1 (en) Thiopene derivatives as antiviral agents
EA201790810A1 (ru) Активная композиция для мягчителя ткани
PH12022552034A1 (en) Pyridone derivative having tetrahydropyranyl methyl group
CR20130501A (es) Derivados novedosos de cefalosporinas y composiciones farmacéuticas de estos
BR112015020904A2 (pt) microrganismos e métodos para produção de butadieno e compostos relacionados por assimilação de formiato
BR112017008176A2 (pt) método de preparação do carbonato de ácido glicérico.
EP4599830A3 (en) Isoxazoline compounds for use in treating demodicosis
PH12014502752A1 (en) Novel cyclic depsipeptide derivative and pest control agent compromising same
SG10201807891UA (en) Hexose derivatives, preparation and uses thereof
MX2016002281A (es) Metodo para la produccion industrial de harina de biomasa de microalgas ricas en lipidos sin "mal sabor" al controlar la disponibilidad del oxigeno.
MX390799B (es) Sintesis de complejo de zinc-lisina a partir de cloruro de zinc.
NZ603261A (en) Anticancer steroidal lactones unsaturated in position 7 (8)
PH12016500461A1 (en) Polyethylene glycol-containing composition
SG10201805880UA (en) Emulsion composition for skin
MX2018004696A (es) Analogos de epotilona, metodos de sintesis, metodos de tratamiento y conjugados con farmacos de los mismos.
MX355222B (es) Proceso industrial para la sintesis de acetato de ulipristal y su analogo 4'-acetil.
PH12016500788A1 (en) Compounds for the treatment of diabetes and disease complications arising from same
PH12014501676B1 (en) Plant disease control composition
BR112015023730A2 (pt) uso de sedoeptulose como suplemento nutricional